AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $34K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$34K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $2.57
- 52-wk high
- $4.54
- High
- $2.63
- 52-wk low
- $1.66
- Low
- $2.51
- Prev close
- $2.52
- Mkt cap
- $402.4M
- Volume
- 2.16M
- Beta
- 2.09
- P/S
- 8.6x
- P/B
- 3.9x
- Profit margin
- -157.3%
- Op margin
- -167.3%
- ROE
- -118.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EDIT filings
Are insiders buying or selling Editas Medicine Inc (EDIT) stock?
Net selling: insiders sold $34K and bought $0 of EDIT stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $34K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was O'Neill, Gilmore Neil (CEO), who sold $16K. The latest filing was on Sep 4, 2026.
Which members of Congress have traded EDIT recently?
None. No member of Congress disclosed a EDIT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EDIT smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in EDIT right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 9, 2026, in 35 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -157.3%
- Market cap
- $402M
Valuation
- P/S8.56
- P/B3.90
Quality
- Operating margin-167.3%
- ROE-118.8%
- ROA-23.3%
Growth
- Beta2.09
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace